Berbevis Dose-finding Study in Subjects With Impaired Fasting Glucose

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Impaired Fasting Glucose (IFG)
Interventions
DIETARY_SUPPLEMENT

Berbevis supplement

This intervention consists of a standardized oral dietary supplement containing Berberis aristata extract formulated in phospholipids (Berbevis™). The supplement is formulated to support metabolic balance. It is administered twice daily for 8 weeks to evaluate safety, tolerability, and dose-response effects in healthy adult volunteers.

All Listed Sponsors
lead

Azienda di Servizi alla Persona di Pavia

OTHER

NCT06955234 - Berbevis Dose-finding Study in Subjects With Impaired Fasting Glucose | Biotech Hunter | Biotech Hunter